Search for: "State v. Nano" Results 1 - 20 of 56
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Aug 2011, 11:10 am by Robert Oszakiewski
Honda and then California State Controller Steve Westly in 2004. [read post]
26 Mar 2008, 1:40 pm
Friends of the Earth Australia, Europe, United States, and Germany (FOE) recent published "Out of the Laboratory and On to Our Plates: Nanotechnology in Food and Agriculture. [read post]
20 May 2011, 12:34 pm by Jonathan Zasloff
The Tata Nano: Bodacious Enough for US Jurisdiction? [read post]
19 Oct 2007, 11:06 am
Nohynel concluded by stating that "[o]verall, the weight of current scientific evidence suggest that the use of nano-sized cosmetic or sunscreen ingredients poses no or negligible potential risk to human health. [read post]
19 Jun 2009, 1:28 pm
He further stated that "we have seen some companies drop the 'nano' claim while continuing to use nanotechnology. [read post]
11 Jan 2008, 2:50 pm
  Regarding nanotoxicology, the task-force finds two texts provide the best overview of the state of current science: (i) K. [read post]
16 Aug 2023, 8:07 am by Lynn L. Bergeson and Carla N. Hutton
In the case of nanomaterials not listed in Annexes IV, V, and VI, notifications must include additional data on the safety of the nanomaterial for use in cosmetic products. [read post]
29 Dec 2016, 4:13 am by Edith Roberts
” At LawNewz, Elura Nanos looks at American Business USA Corp. v. [read post]
3 Mar 2008, 9:59 am
   CRS suggests reevaluating how nano-EHS research money is divided between federal agencies given priority research topics. [read post]
16 May 2006, 2:05 pm
Original Source: Creative sues Apple over iPod Interface [MacNN] Prior Posts:Sep. 12, 2005 - Creative v. [read post]
24 Aug 2022, 8:18 am by Steven Cohen
Facts:  This case (Burrows et al v. 3M Company – United States District Court – Western District of Washington – August 12, 2022) involves a personal injury claim. [read post]
30 Oct 2011, 6:35 pm by FDABlog HPM
”  However, the use of other “nano” terms for specific sectors, such as pharmaceuticals, is not precluded. [read post]